Developed by Metabolic Pharmaceuticals in Australia, AOD-9604 was engineered to retain the fat-reducing properties of intact growth hormone while eliminating the undesirable effects on glucose metabolism, insulin sensitivity, and tissue growth
In proof-of-concept studies, NNMT inhibitors (NNMTis) have demonstrated promise as potential treatments for obesity and obesity-related metabolic comorbidities (e.g., T2D, fatty liver) 8,9,13
issued a recall of one lot of Infla-650 Herbal Dietary Capsules because they were found to contain acetaminophen, diclofenac, and phenylbutazone
BPC-157 is part of a doctor-supervised peptide therapy program and requires a medical consultation before initiation.
At Sacramento Naturopathic Medical Center, our regenerative approach promotes genuine tissue healing rather than symptom suppression
M., Wilson-Heid, A., & De, A